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Background
Stevens-Johnson syndrome (SJS) / toxic epidermal necro-
lysis (TEN), and drug reaction with eosinophilia and
systemic symptoms (DRESS) / drug-induced hypersensi-
tivity syndrome (DIHS) are recognized as severe cutaneous
adverse reactions (SCARs) usually induced by drugs. Due
to the high risk of mortality, management of patients with
SCARs requires rapid diagnosis. However, it is difficult to
distinguish the early phase of SJS/ TEN and DIHS/DRESS
from other ordinary types of drug-induced skin reactions.
Therefore, there is a strong need of diagnostic markers for
early stage of SCARs.
Objective
In this study, we focused on chemokine productions in
DIHS/DRESS and SJS/TEN. To determine whether che-
mokines might be useful markers for early diagnosis of
SCARs, we examined the kinetics of chemokines during
the course of the disease.
Methods
Sera were obtained from 42 DRESS/DIHS patients asso-
ciated with HHV-6 reactivation (n=31) and without
HHV-6 reactivation (n=11), 16 SJS/TEN patients,
and 17 patients with drug-induced maculopapular
exanthema (MPE) in the acute and convalescent stage.
Serum levels of Th1 chemokines (IP-10 and RANTES)
and Th2 chemokines (TARC and MDC) were measured
by ELISA.
Results
We observed that serum TARC and MDC levels in
patients with DRESS/DIHS were markedly higher than
those in SJS/TEN and MPE patients in the acute stage
(P<0.00003 in both cases). Furthermore, these levels are
closely associated with HHV-6 reactivation. On the
other hand, serum IP-10 showed significantly higher
levels in SJS/TEN than DRESS/DIHS and MPE in the
acute stage (P< 0.006 and P <0.0002, respectively),
whereas there were no significant differences in serum
RANTES levels among these three groups.
Conclusion
We suggest that TARC and MDC could be useful diag-
nostic markers for DRESS/DIHS at early stage, and that
IP-10, but not RANTES, might be a helpful indicator for
differentiating SJS/TEN from other drug eruptions.
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